Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Allison Whitten AstraZeneca reports mixed Phase 3 results across oncology and rare disease AstraZeneca reported mixed late-stage clinical results, with its Claudin 18.2-targeting antibody-drug conjugate sonesitatug vedotin meeting its primary endpoint in patients with previously treated advanced gastric cancer, while rare disease therapy Ultomiris missed the primary endpoint in a Phase 3 trial for thrombotic microangiopathy following haematopoietic stem cell transplantation (HSCT-TMA)
Therefore, unless written otherwise, "ascorbate" and "ascorbic acid" refer in the nutritional literature to l-ascorbate and l-ascorbic acid respectively
Expression of Glycosaminoglycans and Small Proteoglycans in Wounds: Modulation by theTripeptideCopper Complex Glycyl-L-Histidyl-L-Lysine-Cu2+ 9
Unauthorized sharing or duplication is strictly prohibited
US$ 23.36
US$ 20.72
US$ 26.52
US$ 22.74
